Comparison of 4D CT, ultrasonography, and 99mTc sestamibi SPECT/CT in localizing single-gland primary hyperparathyroidism.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 25518904.
- Also identified by DOI 10.1177/0194599814562195.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The present study was designed to evaluate 4D computerized tomography (CT) as a means of localizing abnormal parathyroid glands in primary hyperparathyroidism (HPT). Case series with expertized image review. Tertiary care hospital. A total of 38 patients were recruited for study, all of whom had undergone focused parathyroidectomy for single-lesion primary HPT between June 2011 and September 2013. In each patient, 3 imaging procedures were performed: cervical ultrasonography (US), 99mTc-sestamibi SPECT/CT (SeS), and 4D CT. Collective imaging data were blindly reviewed and compared. 4D CT outperformed US and SeS in terms of sensitivity (P=.27), specificity (P=.01), positive predictive value (PPV) (P<.01), negative predictive value (NPV) (P=.19), and accuracy (P<.01). In 7.9% (3/38) of patients, 4D CT provided specific anatomic information that was unaffordable by US and SeS. Localization by 4D CT correlated with tissue parathyroid hormone level (P=.02), maximum diameter (P=.01), and volume (P<.01) of abnormal parathyroid glands. 4D CT proved helpful in localizing target parathyroid glands of primary HPT that were missed by traditional imaging.
Medical subject headings
- Four-Dimensional Computed Tomography
- Hyperparathyroidism, Primary
- Multidetector Computed Tomography
- Technetium Tc 99m Sestamibi
- Tomography, Emission-Computed, Single-Photon
- Ultrasonography, Doppler, Color